Page last updated: 2024-08-22

silver and Heart Valve Diseases

silver has been researched along with Heart Valve Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's5 (83.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Butchart, EG; Fraser, AG; Giddings, J; Grunkemeier, GL; Ionescu, A; Payne, N1
Carrel, T; Grunkemeier, GL; Holubkov, R; Schaff, H; Steckelberg, JM1
Herold, U; Jakob, H; Piotrowski, J; Van De Wal, H1
Flameng, W; Herijgers, P; Herregods, MC; Meyns, B; Vandeplas, A1
Auer, J; Berent, R; Eber, B; Hartl, P; Lassnig, E; Mayr, H; Ng, CK; Punzengruber, C; Puschmann, R; Schwarz, C1
Hillion, ML; Houël, R; Kirsch, M; Loisance, D1

Trials

2 trial(s) available for silver and Heart Valve Diseases

ArticleYear
Artificial Valve Endocarditis Reduction Trial (AVERT): protocol of a multicenter randomized trial.
    The Journal of heart valve disease, 1999, Volume: 8, Issue:2

    Topics: Clinical Protocols; Coated Materials, Biocompatible; Endocarditis, Bacterial; Follow-Up Studies; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Heart Valves; Humans; Prosthesis-Related Infections; Randomized Controlled Trials as Topic; Silver; Surveys and Questionnaires; Treatment Outcome

1999
Silzone coating and paravalvular leak: an independent, randomized study.
    The Journal of heart valve disease, 2001, Volume: 10, Issue:6

    Topics: Aged; Cohort Studies; Echocardiography; Female; Follow-Up Studies; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; L-Lactate Dehydrogenase; Male; Middle Aged; Outcome Assessment, Health Care; Prosthesis Failure; Silver; Time Factors

2001

Other Studies

4 other study(ies) available for silver and Heart Valve Diseases

ArticleYear
Incidence of embolism and paravalvar leak after St Jude Silzone valve implantation: experience from the Cardiff Embolic Risk Factor Study.
    Heart (British Cardiac Society), 2003, Volume: 89, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aortic Valve; Female; Follow-Up Studies; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mitral Valve; Postoperative Complications; Prospective Studies; Risk Factors; Silver; Stroke; Survival Analysis; Thromboembolism

2003
Disruption of the silver and non-silver coated sewing cuff of a new generation bileaflet valve prosthesis during aortic valve replacement: report on four cases.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2000, Volume: 18, Issue:2

    Topics: Aortic Valve; Coated Materials, Biocompatible; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Intraoperative Complications; Prosthesis Failure; Silver; Sutures

2000
Early investigation of silver-coated Silzone heart valves prosthesis in 126 patients.
    The Journal of heart valve disease, 2001, Volume: 10, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Echocardiography; Female; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hospital Mortality; Humans; Male; Middle Aged; Postoperative Complications; Prosthesis Failure; Silver; Stroke; Time Factors; Treatment Outcome

2001
Silzone-coated St. Jude medical valve: a safe valve.
    The Journal of heart valve disease, 2001, Volume: 10, Issue:6

    Topics: Actuarial Analysis; Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Male; Middle Aged; Prosthesis Failure; Risk Factors; Silver; Thromboembolism; Time Factors

2001